BioNTech SE (BNTX) Assets Average (2019 - 2025)
BioNTech SE (BNTX) posted Assets Average of $25.3 billion for Q4 2025, up 2.23% sequentially from $24.7 billion in Q3 2025, and up 3.84% YoY from $24.3 billion in Q4 2024.
BioNTech SE (BNTX) Assets Average (2019 - 2025) Analysis & Trends
BioNTech SE has reported Assets Average for 7 years, with the latest figure at $25.3 billion in Q4 2025.
- Quarterly Assets Average rose 3.84% year-over-year to $25.3 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $25.3 billion (up 3.84% YoY) and the FY2025 annual result came in at $24.5 billion, changed 0.18% from the prior year.
- Assets Average rose to $25.3 billion in Q4 2025 per BNTX's latest filing, from $24.7 billion in the prior quarter.
- Over five years, Assets Average peaked at $25.3 billion in Q4 2025 and troughed at $3.9 billion in Q1 2021.
- A 5-year average of $21.1 billion and a median of $23.6 billion in 2023 frame the typical range for Assets Average.
- The sharpest annual moves came in 2021 and 2025: Assets Average surged 905.48% in 2021, then retreated 5.26% in 2025.
- Over 5 years, Assets Average stood at $17.4 billion in 2021, then soared by 33.54% to $23.3 billion in 2022, then climbed by 5.0% to $24.5 billion in 2023, then fell by 0.51% to $24.3 billion in 2024, then climbed by 3.84% to $25.3 billion in 2025.
- According to Business Quant data, Assets Average over the past three periods registered $25.3 billion, $24.7 billion, and $23.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn | 25.27 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 25.27 Bn |
| Sep 30, 2025 | 24.72 Bn |
| Jun 30, 2025 | 23.39 Bn |
| Mar 31, 2025 | 23.18 Bn |
| Dec 31, 2024 | 24.34 Bn |
| Sep 30, 2024 | 24.27 Bn |
| Jun 30, 2024 | 24.06 Bn |
| Mar 31, 2024 | 24.47 Bn |
| Dec 31, 2023 | 24.46 Bn |
| Sep 30, 2023 | 24.19 Bn |
| Jun 30, 2023 | 23.95 Bn |
| Mar 31, 2023 | 23.72 Bn |
| Dec 31, 2022 | 23.30 Bn |
| Sep 30, 2022 | 22.71 Bn |
| Jun 30, 2022 | 22.68 Bn |
| Mar 31, 2022 | 20.45 Bn |
| Dec 31, 2021 | 17.45 Bn |
| Sep 30, 2021 | 13.90 Bn |
| Jun 30, 2021 | 8.04 Bn |
| Mar 31, 2021 | 3.92 Bn |